Psyence Biomedical (PBM) Operating Expenses (2023 - 2025)

Psyence Biomedical's Operating Expenses history runs 3 years deep, the most recent figure standing at $573339.0 for Q3 2025.

• On a quarterly basis, Operating Expenses rose 12.49% year-over-year to $573339.0 in Q3 2025; TTM through Mar 2026 was $1.1 million, a 123.29% increase from a year earlier, with the FY2026 full-year figure at $2.4 million, up 52.41% from the prior year.
• Operating Expenses climbed to $573339.0 in Q3 2025 per PBM's latest filing, from $509686.0 in the prior quarter.
• Across five years, Operating Expenses topped out at $573339.0 in Q3 2025 and bottomed at -$24662.0 in Q3 2023.
• The 3-year median for Operating Expenses is $509686.0 (2024), against an average of $352787.7.
• Across the five-year window, Operating Expenses surged 2166.69% in 2024 and gained 12.49% in 2025, its largest moves.
• Year by year, Operating Expenses stood at -$24662.0 in 2023, then jumped by 2166.69% to $509686.0 in 2024, then advanced by 12.49% to $573339.0 in 2025.
• Per Business Quant, the three latest PBM Operating Expenses figures stand at $573339.0 (Q3 2025), $509686.0 (Q3 2024), and -$24662.0 (Q3 2023).